Treatment of Complex Regional Pain Syndrome type I;A randomised, double-blind, placebo-controlled study with multiple rounds of S(+)-ketamine infusions (The Ket Ket Study)
- Conditions
- CRPS-1chronic pain10034606
- Registration Number
- NL-OMON31841
- Lead Sponsor
- eids Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Not specified
- Target Recruitment
- 30
• Patients are diagnosed with CRPS-1 according to the IASP-criteria;
• Patients must report a NRS spontaneous pain score of 5 or higher;
• The age of the patient is between 18 and 70 years;
• Patients must give a written informed consent;
• Patients who are not able to give informed consent;
• Patients suffering from other syndromes/diseases interfering with pain ratings;
• Patients who have had previous ketamine continuous infusion;
• Patients with co-morbidity such as: kidney disease, severe liver disease, nerve damage in the
affected area, increased intracranial pressure, infectious disease, epilepsy, a psychiatric
illness, thyroid disease, cancer, cardiac disease, pulmonary disease, severe or uncontrolled
hypertension, aneurysm, glaucoma, history of cerebral vascular accident (CVA) < 1 year;
• Patients who are pregnant.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method